Maxposure Ltd.
•₹ 30.15-3.05%
2026-08-21
PROS
- Company has a healthy return on capital (ROCE) of 21.3%
- Operating margins have improved to 20.2% from 3.9%
- Working capital cycle has improved - days down from 210 to 123
- Company comfortably covers its interest (38.4x coverage)
- Company maintains a comfortable, low leverage position
CONS
- Operating cash flow has been negative in recent years
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.19x)
- Equity base is being diluted - shares outstanding up 584.9%
- Total debt has risen sharply - up 426.6% year on year
- Free cash flow has been persistently negative
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SIGNPOST | 266.05 | 19.34 | 1422.04 | 0.19 | 18.66 | 22.18 | 152.26 | 10.62 | 15.95 | 22.54 |
| 2. | RKSWAMY | 94.60 | 21.04 | 477.51 | 2.11 | 3.46 | 20.52 | 83.62 | 7.80 | 12.87 | 10.44 |
| 3. | MAXPOSURE | 31.85 | 7.64 | 72.43 | 0.00 | — | — | — | — | 15.98 | — |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
No standalone quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 20 | 33 | 32 | 43 | 54 | |
| 21 | 32 | 26 | 33 | 43 | |
| Operating Profit | 2 | 1 | 7 | 11 | 12 |
| OPM % | 8 | 4 | 23 | 26 | 23 |
| Other Income | 2 | 1 | 2 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 0 |
| Depreciation | 0 | 0 | 0 | 1 | 1 |
| 0 | 0 | 6 | 11 | 11 | |
| Tax % | 26 | 13 | 27 | 29 | 25 |
| Net Profit | 0 | 0 | 4 | 8 | 8 |
| EPS | 0 | 0 | 1 | 3 | 4 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | 0 | 0 | 3 | 4 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | 0 | 0 | 3 | 4 |
Mar 2021
- 20
- 21
- Operating Profit
- 2
- OPM %
- 8
- Other Income
- 2
- Interest
- 1
- Depreciation
- 0
- 0
- Tax %
- 26
- Net Profit
- 0
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2022
- 33
- 32
- Operating Profit
- 1
- OPM %
- 4
- Other Income
- 1
- Interest
- 1
- Depreciation
- 0
- 0
- Tax %
- 13
- Net Profit
- 0
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2023
- 32
- 26
- Operating Profit
- 7
- OPM %
- 23
- Other Income
- 2
- Interest
- 1
- Depreciation
- 0
- 6
- Tax %
- 27
- Net Profit
- 4
- EPS
- 1
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2024
- 43
- 33
- Operating Profit
- 11
- OPM %
- 26
- Other Income
- 1
- Interest
- 1
- Depreciation
- 1
- 11
- Tax %
- 29
- Net Profit
- 8
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2025
- 54
- 43
- Operating Profit
- 12
- OPM %
- 23
- Other Income
- 1
- Interest
- 0
- Depreciation
- 1
- 11
- Tax %
- 25
- Net Profit
- 8
- EPS
- 4
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 18%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 188%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -48%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 10%
- 3 Years:
- 16%
- Last Year:
- 14%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - |
| Equity Capital | 3 | 3 | 3 | 23 | 23 |
| 23 | 23 | 28 | 33 | 42 | |
| 3 | 2 | 2 | 0 | 7 | |
| Trade Payables | 6 | 6 | 11 | 4 | 2 |
| 4 | 9 | 5 | 10 | 10 | |
| Total Liabilities | 40 | 45 | 49 | 71 | 84 |
| ASSETS | - | - | - | - | - |
| 2 | 1 | 3 | 3 | 3 | |
| 13 | 13 | 26 | 28 | 38 | |
| 0 | 0 | 0 | 16 | 15 | |
| Cash & Bank | 3 | 3 | 2 | 19 | 11 |
| 21 | 27 | 17 | 4 | 15 | |
| Total Assets | 40 | 45 | 49 | 71 | 84 |
| Total Debt | 4 | 3 | 3 | 1 | 8 |
| Net Working Capital | 11 | 10 | 3 | 25 | 18 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 7.92 | 8.03 | 9.36 | 24.73 | 28.41 |
| Face Value | 1.00 | 1.00 | 1.00 | 10.00 | 10.00 |
| Total Debt | 4 | 3 | 3 | 1 | 8 |
| Net Working Capital | 11 | 10 | 3 | 25 | 18 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 7.92 | 8.03 | 9.36 | 24.73 | 28.41 |
| Face Value | 1.00 | 1.00 | 1.00 | 10.00 | 10.00 |
Mar 2021
- Equity Capital
- 3
- 23
- 3
- Trade Payables
- 6
- 4
- Total Liabilities
- 40
- 2
- 13
- 0
- Cash & Bank
- 3
- 21
- Total Assets
- 40
- Total Debt
- 4
- Net Working Capital
- 11
- Contingent Liabilities
- 0
- Book Value per Share
- 7.92
- Face Value
- 1.00
- Total Debt
- 4
- Net Working Capital
- 11
- Contingent Liabilities
- 0
- Book Value per Share
- 7.92
- Face Value
- 1.00
Mar 2022
- Equity Capital
- 3
- 23
- 2
- Trade Payables
- 6
- 9
- Total Liabilities
- 45
- 1
- 13
- 0
- Cash & Bank
- 3
- 27
- Total Assets
- 45
- Total Debt
- 3
- Net Working Capital
- 10
- Contingent Liabilities
- 0
- Book Value per Share
- 8.03
- Face Value
- 1.00
- Total Debt
- 3
- Net Working Capital
- 10
- Contingent Liabilities
- 0
- Book Value per Share
- 8.03
- Face Value
- 1.00
Mar 2023
- Equity Capital
- 3
- 28
- 2
- Trade Payables
- 11
- 5
- Total Liabilities
- 49
- 3
- 26
- 0
- Cash & Bank
- 2
- 17
- Total Assets
- 49
- Total Debt
- 3
- Net Working Capital
- 3
- Contingent Liabilities
- 0
- Book Value per Share
- 9.36
- Face Value
- 1.00
- Total Debt
- 3
- Net Working Capital
- 3
- Contingent Liabilities
- 0
- Book Value per Share
- 9.36
- Face Value
- 1.00
Mar 2024
- Equity Capital
- 23
- 33
- 0
- Trade Payables
- 4
- 10
- Total Liabilities
- 71
- 3
- 28
- 16
- Cash & Bank
- 19
- 4
- Total Assets
- 71
- Total Debt
- 1
- Net Working Capital
- 25
- Contingent Liabilities
- 0
- Book Value per Share
- 24.73
- Face Value
- 10.00
- Total Debt
- 1
- Net Working Capital
- 25
- Contingent Liabilities
- 0
- Book Value per Share
- 24.73
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 23
- 42
- 7
- Trade Payables
- 2
- 10
- Total Liabilities
- 84
- 3
- 38
- 15
- Cash & Bank
- 11
- 15
- Total Assets
- 84
- Total Debt
- 8
- Net Working Capital
- 18
- Contingent Liabilities
- 0
- Book Value per Share
- 28.41
- Face Value
- 10.00
- Total Debt
- 8
- Net Working Capital
- 18
- Contingent Liabilities
- 0
- Book Value per Share
- 28.41
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| -2 | 1 | 1 | -1 | -4 | |
| Cash from Investing | -0 | 1 | -1 | -4 | -10 |
| Cash from Financing | -1 | -2 | -0 | 22 | 6 |
| -3 | 0 | -1 | 17 | -8 | |
| Free Cash Flow | -2 | 1 | -1 | -2 | -5 |
| OCF / Net Profit | -5.28 | 2.91 | 0.16 | -0.12 | -0.45 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 |
| OCF / Net Profit | -5.28 | 2.91 | 0.16 | -0.12 | -0.45 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 |
Mar 2021
- -2
- Cash from Investing
- -0
- Cash from Financing
- -1
- -3
- Free Cash Flow
- -2
- OCF / Net Profit
- -5.28
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -5.28
- Cumulative 5-Year FCF
- 0
Mar 2022
- 1
- Cash from Investing
- 1
- Cash from Financing
- -2
- 0
- Free Cash Flow
- 1
- OCF / Net Profit
- 2.91
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.91
- Cumulative 5-Year FCF
- 0
Mar 2023
- 1
- Cash from Investing
- -1
- Cash from Financing
- -0
- -1
- Free Cash Flow
- -1
- OCF / Net Profit
- 0.16
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.16
- Cumulative 5-Year FCF
- 0
Mar 2024
- -1
- Cash from Investing
- -4
- Cash from Financing
- 22
- 17
- Free Cash Flow
- -2
- OCF / Net Profit
- -0.12
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.12
- Cumulative 5-Year FCF
- 0
Mar 2025
- -4
- Cash from Investing
- -10
- Cash from Financing
- 6
- -8
- Free Cash Flow
- -5
- OCF / Net Profit
- -0.45
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.45
- Cumulative 5-Year FCF
- 0
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - |
| EPS (₹) | 0.11 | 0.11 | 1.33 | 3.39 | 3.69 |
| Book Value (₹) | 7.92 | 8.03 | 9.36 | 24.73 | 28.41 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 0.04 | 0.04 | 0.29 | 3.63 | 4.02 |
| PROFITABILITY | - | - | - | - | - |
| Operating Margin % | 8.15% | 3.86% | 22.62% | 23.92% | 20.19% |
| Net Margin % | 1.80% | 1.07% | 13.88% | 18.02% | 15.56% |
| ROE % | 1.38% | 1.32% | 15.28% | 17.67% | 13.88% |
| ROCE % | 4.21% | 3.14% | 21.33% | 24.84% | 17.69% |
| 0.91% | 0.83% | 9.48% | 12.96% | 10.87% | |
| EFFICIENCY | - | - | - | - | - |
| Debtor Days | 119 | 97 | 124 | 114 | 106 |
| Inventory Days | 5 | 2 | 3 | 3 | 3 |
| Payable Days | 0 | 4714 | 2663 | 1519 | 538 |
| 124 | -4616 | -2537 | -1401 | -429 | |
| FINANCIAL HEALTH | - | - | - | - | - |
| Debt to Equity (x) | 0.16x | 0.11x | 0.11x | 0.03x | 0.12x |
| Interest Coverage (x) | 1.62x | 1.74x | 8.83x | 21.92x | 38.39x |
| 1.88x | 1.59x | 1.20x | 2.98x | 2.04x | |
| GROWTH | - | - | - | - | - |
| Revenue Growth % | 0.00% | 62.12% | -2.73% | 34.68% | 25.90% |
| Operating Profit Growth % | 0.00% | -23.16% | 469.42% | 54.24% | 10.56% |
| Net Profit Growth % | 0.00% | -3.48% | 1162.04% | 74.84% | 8.69% |
| 0.00% | 0.00% | 0.00% | 155.26% | 8.69% | |
| VALUATION | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 24.13x | 15.28x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 3.31x | 1.98x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 15.21x | 10.18x |
Mar 2021
- EPS (₹)
- 0.11
- Book Value (₹)
- 7.92
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.04
- Operating Margin %
- 8.15%
- Net Margin %
- 1.80%
- ROE %
- 1.38%
- ROCE %
- 4.21%
- 0.91%
- Debtor Days
- 119
- Inventory Days
- 5
- Payable Days
- 0
- 124
- Debt to Equity (x)
- 0.16x
- Interest Coverage (x)
- 1.62x
- 1.88x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 0.11
- Book Value (₹)
- 8.03
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.04
- Operating Margin %
- 3.86%
- Net Margin %
- 1.07%
- ROE %
- 1.32%
- ROCE %
- 3.14%
- 0.83%
- Debtor Days
- 97
- Inventory Days
- 2
- Payable Days
- 4714
- -4616
- Debt to Equity (x)
- 0.11x
- Interest Coverage (x)
- 1.74x
- 1.59x
- Revenue Growth %
- 62.12%
- Operating Profit Growth %
- -23.16%
- Net Profit Growth %
- -3.48%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 1.33
- Book Value (₹)
- 9.36
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.29
- Operating Margin %
- 22.62%
- Net Margin %
- 13.88%
- ROE %
- 15.28%
- ROCE %
- 21.33%
- 9.48%
- Debtor Days
- 124
- Inventory Days
- 3
- Payable Days
- 2663
- -2537
- Debt to Equity (x)
- 0.11x
- Interest Coverage (x)
- 8.83x
- 1.20x
- Revenue Growth %
- -2.73%
- Operating Profit Growth %
- 469.42%
- Net Profit Growth %
- 1162.04%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 3.39
- Book Value (₹)
- 24.73
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 3.63
- Operating Margin %
- 23.92%
- Net Margin %
- 18.02%
- ROE %
- 17.67%
- ROCE %
- 24.84%
- 12.96%
- Debtor Days
- 114
- Inventory Days
- 3
- Payable Days
- 1519
- -1401
- Debt to Equity (x)
- 0.03x
- Interest Coverage (x)
- 21.92x
- 2.98x
- Revenue Growth %
- 34.68%
- Operating Profit Growth %
- 54.24%
- Net Profit Growth %
- 74.84%
- 155.26%
- P/E (x)
- 24.13x
- P/B (x)
- 3.31x
- Dividend Yield %
- 0.00%
- 15.21x
Mar 2025
- EPS (₹)
- 3.69
- Book Value (₹)
- 28.41
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.02
- Operating Margin %
- 20.19%
- Net Margin %
- 15.56%
- ROE %
- 13.88%
- ROCE %
- 17.69%
- 10.87%
- Debtor Days
- 106
- Inventory Days
- 3
- Payable Days
- 538
- -429
- Debt to Equity (x)
- 0.12x
- Interest Coverage (x)
- 38.39x
- 2.04x
- Revenue Growth %
- 25.90%
- Operating Profit Growth %
- 10.56%
- Net Profit Growth %
- 8.69%
- 8.69%
- P/E (x)
- 15.28x
- P/B (x)
- 1.98x
- Dividend Yield %
- 0.00%
- 10.18x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.